0
Letters |

Treatment for Individuals With HIV/AIDS Following Release From Prison

Ingrid A. Binswanger, MD, MPH; Hal S. Wortzel, MD
JAMA. 2009;302(2):147-148. doi:10.1001/jama.2009.919.
Text Size: A A A
Published online

Extract

To the Editor: Dr Baillargeon and colleagues1 offered compelling evidence of the poor continuity of care for individuals with human immunodeficiency virus (HIV)/AIDS transitioning to community-based health care following release from prison. This study documented discontinuity in antiretroviral therapy, but many other chronic medical conditions are affected by poor transitions of care, including diabetes, asthma, and mental illness. Disenrollment of inmates from Medicaid, Medicare, and veterans' benefits during incarceration means that even those eligible for such benefits face substantial lag time in re-enrollment at release. Former inmates may resort to costly health care utilization to have basic medical needs met,2 resulting in inappropriate use of scarce public resources for health care. Discharge planning through the AIDS Drug Assistance Program may help reduce discontinuities in prescription drug treatment for individuals with HIV/AIDS, but for most inmates with chronic disease, such programs are unavailable. Interruptions in care can result in increased recidivism, medicolegal consequences, and mortality.35

Topics

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

July 8, 2009
Keith Barton, MD
JAMA. 2009;302(2):147-148. doi:10.1001/jama.2009.920.
July 8, 2009
Jacques Baillargeon, PhD; David P. Paar, MD; Josiah D. Rich, MD, MPH
JAMA. 2009;302(2):147-148. doi:10.1001/jama.2009.921.
CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs